Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NATHBIOGEN
NATHBIOGEN
131.40+0.9 (+0.69%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

22.5 / 100

Value Score

92.5 / 100

Price Momentum Score

35.0 / 100

QVM Score

46.4 / 100

Key Metrics

Market Cap
249.71
P/E (TTM)
6.82
P/B
0.37
P/S (TTM)
0.51
EV/EBITDA
3.02
CAPE (5Y)
17.48
ROE (TTM)
6.28
ROCE (TTM)
6.11
ROA (TTM)
3.92
Avg 3Y ROE
6.38
Earnings 3Y CAGR
-2.21
Sales 3Y CAGR
14.38
Sales 5Y CAGR
8.29
Debt/Equity
0.20
Consensus TP
-
Strong Buy %
-
Promoter Holding
45.60
Pledged %
13.78

Share Price

Track Nath Bio-Genes (India) Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

131.400.9 (0.69%) D
-22.53% in past 1 year
1 Week returns: -6.80 %
Low
127.7
High
138.9
1 Month returns: -12.40 %
Low
127.7
High
154.9
1 Year returns: -23.40 %
Low
126.2
High
207.0
3 Year CAGR: -11.98 %
Low
126.2
High
264.3
5 Year CAGR: -15.45 %
Low
126.2
High
331.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Nath Bio-Genes (India) Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 6.82 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -54.59%

What is P/E Ratio?

Median: 15.02
Value 6.82
1.04356.63
Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Not enough talking points with negative stance
Neutral
Company's earnings are of moderate quality

Earnings quality score of 37.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

37.7 / 100

Moderate dividend yield

The company has a moderate dividend yield of 1.52%

What is Dividend yield?

Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.199046.

Financial Snapshot

See detailed analysis

Multi-year trends for Nath Bio-Genes (India) Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k1k301.4 CrMar 2023332.6 CrMar 2024364.9 CrMar 2025445.1 CrMar 2026
Profit After Tax FY
00k0k0k35.0 CrMar 202339.6 CrMar 202438.6 CrMar 202541.6 CrMar 2026
ROE FY
0%2%4%6%8%6.3%Mar 20236.7%Mar 20246.2%Mar 20256.3%Mar 2026
EBITDA FY
00k0k0k48.7 CrMar 202349.9 CrMar 202450.8 CrMar 202552.4 CrMar 2026

Nath Bio-Genes (India) Ltd. Shareholding Pattern

Quarterly breakdown of Nath Bio-Genes (India) Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Promoter
41.79
41.79
41.79
41.79
40.86
41.03
41.03
41.03
41.05
41.07
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
Indian Promoter
41.79
41.79
41.79
41.79
40.86
41.03
41.03
41.03
41.05
41.07
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
45.60
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
9.03
11.04
11.04
11.04
11.05
11.05
9.39
7.21
4.92
4.73
4.63
4.77
4.75
4.70
4.59
4.69
4.64
4.59
4.55
4.56
4.15
2.67
1.08
0.32
0.24
0.28
Mutual Funds / UTI
6.27
8.55
8.55
8.55
8.55
8.55
8.44
7.16
4.85
4.62
4.62
4.62
4.62
4.62
4.37
4.37
4.37
4.37
4.37
4.37
3.89
2.25
0.76
0.01
0.01
0.01
FI/Bank/Insurance
0.27
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.17
0.17
0.17
0.17
0.18
0.18
0.01
0.04
0.07
0.11
0.01
0.15
0.13
0.07
0.22
0.32
0.27
0.21
0.18
0.19
0.21
0.41
0.32
0.31
0.22
0.26
Other Institutions
2.31
2.31
2.31
2.31
2.31
2.31
0.94
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.05
0.00
0.00
0.00
0.00
0.00
Non-Institution
49.18
47.16
47.17
47.17
48.10
47.92
49.58
51.76
54.02
54.20
49.77
49.63
49.65
49.71
49.81
49.72
49.76
49.82
49.85
49.84
50.25
51.74
53.32
54.08
54.17
54.13
Bodies Corporate
21.60
19.25
18.96
20.71
22.22
22.53
22.76
21.92
19.70
18.52
13.43
14.19
14.79
14.61
14.41
14.28
13.14
12.97
13.84
13.79
13.84
13.62
14.23
14.46
14.70
14.54
Others (incl. Retail)
No. of shareholders
27.58
23,230
27.91
23,700
28.21
26,928
26.46
27,007
25.88
25,214
25.39
31,248
26.82
32,847
29.84
33,506
34.32
35,197
35.68
35,086
36.34
35,068
35.44
34,350
34.86
33,571
35.10
33,117
35.40
33,982
35.44
33,879
36.62
34,755
36.85
35,463
36.01
35,029
36.05
34,654
36.41
34,519
38.12
33,822
39.09
33,736
39.62
33,173
39.47
32,659
39.59
32,198

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Nath Bio-Genes (India) Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Nath Bio-Genes (India) Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
AGRI-TECH INDIA LIMITED
Promoter Group
February-2024
Inter-se Transfer (Disposal)
21st Feb 2024
2.65 %₹ 217.005.04 lac₹ 10.94 cr
AKASH FARMS LLP
Promoter Group
February-2024
Inter-se Transfer (Acquisition)
21st Feb 2024
9.59 %₹ 217.005.04 lac₹ 10.94 cr
AGRI-TECH INDIA LIMITED
Promoter Group
December-2023
Inter-se Transfer (Disposal)
25th Dec 2023
3.54 %₹ 211.001.69 lac₹ 3.56 cr
BARKHA FARMS LLP
Promoter Group
December-2023
Inter-se Transfer (Acquisition)
25th Dec 2023
1.86 %₹ 211.001.69 lac₹ 3.56 cr
AGRI-TECH INDIA LIMITED
Promoter Group
December-2023
Market Sale (Disposal)
18th Dec 2023
5.18 %₹ 199.253.12 lac₹ 6.21 cr
AKASH FARMS LLP
Promoter Group
December-2023
Market Purchase (Acquisition)
18th Dec 2023
7.95 %₹ 199.253.12 lac₹ 6.21 cr
AGRI-TECH INDIA LIMITED
Promoter Group
December-2023
Inter-se Transfer (Disposal)
12th Dec 2023
7.87 %₹ 196.005.11 lac₹ 10.01 cr
ASHU FARMS LLP
Promoter Group
December-2023
Inter-se Transfer (Acquisition)
12th Dec 2023
10.99 %₹ 196.005.11 lac₹ 10.01 cr
EMERALD SEEDS PRIVATE LIMITED
Other
August-2022
Market Purchase (Acquisition)
26th Aug 2022
0.00 %₹ 180.066.90 lac₹ 12.42 cr
AGRI-TECH INDIA LIMITED
Promoter Group
August-2022
Market Purchase (Acquisition)
26th Aug 2022
6.97 %₹ 176.941.70 lac₹ 3.01 cr

Corporate Actions

History of Nath Bio-Genes (India) Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 2/share
    Record date: 11th Sep 2026Ex-date: 11th Sep 2026
    Announced on: 4th May 2026
  2. Dividend₹ 2/share
    Record date: 14th Aug 2025Ex-date: 14th Aug 2025
    Announced on: 29th Apr 2025
  3. Dividend₹ 2/share
    Record date: 9th Aug 2024Ex-date: 9th Aug 2024
    Announced on: 8th May 2024
  4. Dividend₹ 2/share
    Record date: 4th Jul 2023Ex-date: 4th Jul 2023
    Announced on: 25th Apr 2023
  5. Dividend₹ 2/share
    Record date: 24th Jun 2022Ex-date: 23rd Jun 2022
    Announced on: 30th May 2022

Company Profile

Overview of Nath Bio-Genes (India) Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Nath Bio-Genes (India) Limited is an India-based company engaged in the business of production, processing, and marketing of hybrid and genetically modified (GM) Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are sit...
Key personnel
Mr. Amol Gupta
Chief Financial Officer
Mr. Dhiraj Rajesh Rathi
Compliance Officer, Company Secretary
Mr. Satish KagliwalD
Managing Director, Director
Mrs. Jeevanlata Nandkishor KagliwalD
Executive Director
Mr. Akash Nandkishor KagliwalD
Non-Executive Director
Mr. Madhukar DeshpandeD
Independent Director
Mr. Vadla NagabhushanamD
Independent Director
Mr. Hitesh Rajnikant PurohitD
Independent Director
View all
Incorporated on
14 Jul 1993
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
452
IPO date
28 Jan 2014
Free Float
72,79,264
Phone no.
+912222871001
Address
1, Chateau Windsor,, 86 Veer Nariman Road,, Churchgate, MUMBAI, 400020, India

Frequently Asked Questions

What is the current share price of Nath Bio-Genes (India) Ltd.?
The current share price of Nath Bio-Genes (India) Ltd. is ₹ 131.40 as of 23 Oct 2026.
What is the market capitalisation of Nath Bio-Genes (India) Ltd.?
The market capitalisation of Nath Bio-Genes (India) Ltd. stands at ₹ 249.71 Cr.
What is the PE ratio of Nath Bio-Genes (India) Ltd.?
The Price-to-Earnings (PE) ratio of Nath Bio-Genes (India) Ltd. is 6.82 as of the latest trailing twelve months data.
What is the ROE and ROCE of Nath Bio-Genes (India) Ltd.?
Nath Bio-Genes (India) Ltd. has a Return on Equity (ROE) of 6.28% and a Return on Capital Employed (ROCE) of 6.11% as per the latest financial reports.
What is the 52-week high and low of Nath Bio-Genes (India) Ltd.?
The 52-week high of Nath Bio-Genes (India) Ltd. is - and the 52-week low is -.
What is the dividend yield of Nath Bio-Genes (India) Ltd.?
The dividend yield of Nath Bio-Genes (India) Ltd. is 1.52% based on the current market price.
What is the FII and DII holding in Nath Bio-Genes (India) Ltd.?
Foreign Institutional Investors (FII) hold 0.26%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 39.59% of Nath Bio-Genes (India) Ltd. shares.
What sector does Nath Bio-Genes (India) Ltd. belong to?
Nath Bio-Genes (India) Ltd. operates in the Fast Moving Consumer Goods sector.
What is the beta of Nath Bio-Genes (India) Ltd.?
The beta of Nath Bio-Genes (India) Ltd. is 0.91, indicating its price volatility relative to the broader market. Over the past 1 year, Nath Bio-Genes (India) Ltd. has delivered an absolute return of -23.21%.
What is the RSI of Nath Bio-Genes (India) Ltd.?
The 14-day Relative Strength Index (RSI) of Nath Bio-Genes (India) Ltd. is 36.19, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.